Navigation Links
Statement from Special Envoy Ray Chambers on the Findings of the WHO Global Tuberculosis Report 2013
Date:10/23/2013

New York, NY (PRWEB) October 23, 2013

Today, the World Health Organization (WHO) released its Global Tuberculosis Report 2013. Ray Chambers, the UN Secretary-General’s Special Envoy for Financing the Health MDGs and for Malaria, acknowledged both the progress and significant remaining challenges highlighted in the report.

“The 2013 report is a forceful call-to-action for more aggressive approaches on a global and country level to fighting tuberculosis. Despite some clear positive trends, including a 45% reduction in TB mortality since 1990, the fact remains that our progress on TB is far too slow. It will take decades at our current pace of progress for developing countries to achieve the same levels of TB mortality of developed nations."

"TB remains a global scourge: it caused 1.3 million deaths in 2012; it contributes significantly to global poverty; and it is a disease with virulent strains that are resistant to existing first-line treatments."

"We must summon the will to do more to get on a path towards defeating tuberculosis. I applaud the WHO for its focus on the need to identify the one third of new cases each year that go undiagnosed, roughly 3 million 'missed' cases out of 8.6 million in 2012. The WHO report calls for important interventions and scale-up of services to health systems so that we can better diagnose, report and treat all people with TB."

"We must also recognize the urgent need to tackle the problem of multi-drug resistant TB (MDR-TB) by summoning high-level political will and heightened cooperation among key partners, including drug regulatory authorities, technical agencies, the pharmaceutical industry and civil society. All must commit to addressing the most lethal and difficult-to-treat strains of the disease. Not doing so is almost sure to result in a public health crisis."

"Finally, we must insure that adequate funding is in place to win this fight. We need a strong replenishment of the Global Fund to Fights AIDS, TB and Malaria at its target level of $15 billion. And we look to the BRICS countries – Brazil, the Russian Federation, India, China and South Africa, which carry nearly 50% of the global TB burden – to increase their domestic funding of their TB response, including a commitment to finding and treating thousands of missing cases."

"We have the tools, the know-how and much of the funding needed to defeat TB. With fewer than 800 days until the 2015 deadline of the Millennium Development Goals, the WHO report challenges us to summon the will to succeed in our quest.”

Read the full story at http://www.prweb.com/releases/2013/10/prweb11259148.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. APA task force recommends treatment guidelines and position statements on transgender persons
2. Joint EACPR and AHA statement empowers health care professional to use Clinical Cardiopulmonary Exercise Testing
3. Probiotic Action Releases a Statement in Regards to a Recent Miami Herald Article on Minimizing Scars
4. Quorn Foods Inc. Releases a Statement Regarding the News of Meat Eaters Turning to Meatless Meals When Dining
5. Quorn Foods Inc. Releases a Statement Regarding the Best Free Vegetarian Smartphone Apps for the Food Lovers Diet
6. Journal Maturitas publishes position statement on diet and health in midlife and beyond
7. Quorn Foods Inc. Releases a Statement Following an Article on Getting the Most Out of a Vegetarian Healthy Food Diet
8. AMSSM issues position statement on sport-related concussions
9. Yumi Media Released a Statement Regarding Ella Dining Room and Bar Offering an All-Vegetarian Menu for Dine Downtown This Year
10. Quorn Foods Inc. Releases a Statement Regarding Vegetarian Healthy Food Options in Meat-Loving Greece
11. NOAA adds red tide alerts to Beach Hazards Statements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces the ... instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ... hour rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: